Close Menu


Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigator Unit Sponsor Date
Connecting Arizonans to Coverage (CA2C) Cooperative Agreement $221,000.00 Other Sponsored Activity Marc Verhougstraete Community Environment & Policy Arizona Alliance for Community Health Centers 01/2022
BRACE: Implementation and Evaluation Grant $450,000.00 Other Sponsored Activity Heidi Brown Epidemiology and Biostatistics Arizona Department of Health Services 01/2022
Study Using Negative Pressure to Reduce Apnea (SUPRA) Contract $166,386.00 Clinical Trial Sairam Parthasarathy Medicine Sommetrics, Inc 01/2022
An Open-Label Long-term Follow-up Study to Evaluate the Effects of Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH Contract $447,126.32 Clinical Trial Franz Rischard Medicine Acceleron Pharmaceuticals 01/2022
A Three-arm, Parallel Group, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of AB-2004 in a 13 to 17 year-old Autism Spectrum Disorder Population Contract $189,110.48 Clinical Trial Sydney Rice Pediatrics Axial Therapeutics, Inc. 01/2022
A Real-World Comparative Effectiveness Trial of Treatment Strategies in Patients With Rheumatoid Arthritis: The RAPRO PRagmatic Trial (RA-PROPR) Contract $35,112.00 Clinical Trial Chian Kwoh Arthritis Center-Research University of Alabama at Birmingham 01/2022
A Randomized, Open Label, Multi-center, Comparative Trial, to Assess the Efficacy and Safety of Pritelivir Versus Foscarnet for the Treatment of Acyclovir-resistant Mucocutaneous HSV Infections in Imm Contract $207,283.75 Clinical Trial Tirdad Zangeneh Medicine AiCuris Anti-Infective Cures (Germany) 01/2022
A Randomized, Double-blind, Placebo-controlled Phase 3 Study of SY-1425 Plus Azacitidine Versus Placebo Plus Azacitidine in Newly Diagnosed, RARA-positive Adult Patients with Higher-risk Myelodysplast Contract $109,845.08 Clinical Trial Sharad Khurana Cancer Center Division Syros Pharmaceuticals, Inc 01/2022
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of Exebacase in Patients Receiving Standard-of-Care Antibiotics for the Treatment of Staphylococcus aur Contract $82,971.76 Clinical Trial Tanya Anand Surgery ContraFect Corp 01/2022
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy fo Contract $989,638.00 Clinical Trial Franz Rischard Medicine Acceleron Pharmaceuticals 01/2022
A Phase 3 Randomized, Double-blind, Multicenter, Global Study of Monalizumab or Placebo in Combination With Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and N Contract $251,744.40 Clinical Trial Ricklie Julian Cancer Center Division Astrazeneca 01/2022
A Phase 1b/2, Randomized, Double-blind, Placebo-controlled, Multi-center Study of STMC-103H in Neonates and Infants at High-risk for Developing Allergic Disease Contract $125,377.52 Clinical Trial Heather Cassell Asthma/Airway Disease Rsch Ctr Siolta Therapeutics 01/2022
A Phase 1b, Dose Escalation and Expansion Study of Lemzoparlimab (TJ011133) With or Without Dexamethasone and in Combination With Anti-Myeloma Regimens for the Treatment of Patients With Relapsed/Refr Contract $1,799,212.70 Clinical Trial Muhammad Husnain Cancer Center Division AbbVie Incorporated 01/2022
A Phase 1a/B Study to Evaluate the Safety and Tolerability of Etc-1922159 in Advanced Solid Tumours Contract $364,303.75 Clinical Trial Aaron Scott Cancer Center Division PPD Investigator Services, LLC. 01/2022
A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients with Acute Respiratory Distress Syndrome Associated.. Contract $3,170,000.00 Clinical Trial Jarrod Mosier Dept of Emergency Medicine Albert Einstein College of Medicine 01/2022
The Effect of Opioids on Fracture Healing Gift $460.50 Research Training David Margolis Orthopedic Surgery Arizona State University 12/2021
Studies on the Interaction Between Piezo1 and TRPV4 Channel in Lens Epithelium (WAESO) Grant $614.00 Research Training Mohammad Shahidullah Physiology Arizona State University 12/2021
Quantitative Histomorphometry of Implanted Composite Ceramic Polymer Scaffolds Grant $460.50 Research Training David Margolis Orthopedic Surgery Arizona State University 12/2021
PCR Analysis of Human and Animal Cells for Tissue Regeneration -WAESO Fall 2021 Grant $460.50 Research Training John Szivek Orthopedic Surgery Arizona State University 12/2021
Deciphering Oncogenic Contributions of Atopobium/Fannyhessea Species to Understand Gynecologic Cancer Utilizing Multi-omic Approaches and 3-D Human Cell Models. Grant $48,500.00 Research Training Nicole Jimenez COM Phx Obstetrics&Gynecology University of Arizona Foundation 12/2021
Compression Testing of Composite Ceramic Polymer Materials Grant $460.50 Research Training David Margolis Orthopedic Surgery Arizona State University 12/2021
Combining Hydrogel Cell Printing with Thermoplastic 3D Printing Grant $460.50 Research Training David Margolis Orthopedic Surgery Arizona State University 12/2021
Exposure Assessment and Risk Impact of Air Dryers Contract $76,997.00 Research - Industry (62.5% MTDC) Kelly Reynolds Community Environment & Policy Excel Dryer, Inc. 12/2021
Blood-Brain Barrier Permeability and Microglia Targeting of Novel Neurotherapeutics Contract $103,855.00 Research - Industry (62.5% MTDC) Patrick Ronaldson Pharmacology Vigil Neuroscience, Inc. 12/2021
A Phase I Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza in Healthy Individuals Contract $85,313.00 Research - Industry (62.5% MTDC) Carol Gregorio Cellular & Molecular Medicine Pfizer, Incorporated 12/2021